Displaying drugs 10176 - 10200 of 10874 in total
GW 597599
GW 597599, a neurokinin-1 (NK1) receptor antagonist is currently in phase II trials for chemotherapy-induced vomiting; functional dyspepsia; depression and anxiety.
Investigational
Matched Description: … GW 597599, a neurokinin-1 (NK1) receptor antagonist is currently in phase II trials for chemotherapy-induced …
Tolperisone
Tolperisone is an oral, centrally acting muscle relaxant. Its precise mechanism is not completely understood, though it blocks sodium and calcium channels. It possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem, spinal cord and peripheral nerves. Based on existing clinical data, Tolperisone is not...
Investigational
Matched Description: … It possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem …
Pittsburgh Compound B
Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).
Investigational
Matched Description: … (Microbleeds) in Atypical AD). ... Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities …
Venanprubart
Venanprubart is under investigation in clinical trial NCT05781451 (Anti-btla Agonist Therapy in Subjects With Primary Sjogren's Syndrome).
Investigational
Matched Description: … Venanprubart is under investigation in clinical trial NCT05781451 (Anti-btla Agonist Therapy in Subjects …
D-Glutamic Acid
Glutamic acid is the most common excitatory neurotransmitter in the central nervous system.
Experimental
Matched Description: … Glutamic acid is the most common excitatory neurotransmitter in the central nervous system. …
Epitizide
Epitizide is an agent, commonly found in combination triamterene, used to produce diuresis.
Experimental
Matched Iupac: … chloro-1,1-dioxo-3-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7- …
Matched Description: … Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis. …
Matched Description: … Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis. …
Neopterin
Neopterin is under investigation in clinical trial NCT02974192 (Neopterin Effects on Ischemic Stroke).
Investigational
Matched Description: … Neopterin is under investigation in clinical trial NCT02974192 (Neopterin Effects on Ischemic Stroke) …
Amylose
Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial).
Investigational
Matched Description: … Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial …
GPI-0100
GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the immune response.
The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety of vaccines, has been shown to have good overall performance characteristics on safety and efficacy.
Investigational
Matched Description: … GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the ... GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety of …
AN-2718
An2718 has been used in trials studying Tinea Pedis.
Investigational
Matched Description: … An2718 has been used in trials studying Tinea Pedis. …
Pipequaline
Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed. It presents a unique chemical structure that does not follow the structural properties of other drugs of its class. Pipequaline has a similar pharmacological profile to the reported for the benzodiazepines. However, it...
Experimental
Matched Description: … of its class. ... It presents a unique chemical structure that does not follow the structural properties of other drugs ... However, it presents a significant set of anxiolytic properties with a very little sedative, amnestic …
Flubendazole
Flubendazole is an anthelmintic that is used to treat worm infection in humans. It is available OTC in Europe.
Experimental
Withdrawn
Matched Description: … It is available OTC in Europe. ... Flubendazole is an anthelmintic that is used to treat worm infection in humans. …
Glucoraphanin
Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]).
Investigational
Matched Description: … in Advanced Pancreatic Cancer [POUDER Trial]). ... Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts …
MOL-4239
MOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis).
Investigational
Matched Description: … Study to Evaluate MOL4239 in Psoriasis). ... MOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, …
BTRX-335140
BTRX-335140 is under investigation in clinical trial NCT04221230 (Study in Major Depressive Disorder With BTRX-335140 vs Placebo).
Investigational
Matched Description: … BTRX-335140 is under investigation in clinical trial NCT04221230 (Study in Major Depressive Disorder …
Pecavaptan
Pecavaptan is under investigation in clinical trial NCT03901729 (A Trial to Study BAY1753011 in Patients With Congestive Heart Failure).
Investigational
Matched Description: … Pecavaptan is under investigation in clinical trial NCT03901729 (A Trial to Study BAY1753011 in Patients …
Gatipotuzumab
Gatipotuzumab is under investigation in clinical trial NCT01899599 (Pankomab-gex™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer).
Investigational
Matched Description: … Therapy in Advanced Ovarian Cancer). ... Gatipotuzumab is under investigation in clinical trial NCT01899599 (Pankomab-gex™ Versus Placebo as Maintenance …
Vamikibart
Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema).
Investigational
Matched Description: … Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in …
Narlumosbart
Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease).
Investigational
Matched Description: … in Patients With Multiple Myeloma Bone Disease). ... Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab …
Vitespen
Investigational
LY-294002
Specific inhibitor of phosphatidylinositol 3-kinase.
Experimental
Matched Description: … Specific inhibitor of phosphatidylinositol 3-kinase. …
Desfesoterodine
Desfesoterodine is a metabolite of tolterodine.
Experimental
Matched Description: … Desfesoterodine is a metabolite of [tolterodine]. …
Matched Products: … TOVEDESO 7 MG RETARDTABL …
Matched Products: … TOVEDESO 7 MG RETARDTABL …
Opaganib
Opaganib, also known as ABC294640, is a selective sphingosine kinase-2 (SK2) (https://go.drugbank.com/polypeptides/Q9NRA0) inhibitor that is orally administered. This drug has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in oncology, inflammation, the gastrointestinal system, and COVID-19.
Investigational
Matched Description: … has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in …
α-Methylfentanyl
α-Methylfentanyl is an analog of fentanyl with opioid analgesic properties.
Illicit
Matched Description: … α-Methylfentanyl is an analog of fentanyl with opioid analgesic properties. …
Vonapanitase
Vonapanitase is under investigation for the treatment of Chronic Kidney Disease.
Investigational
Matched Description: … Vonapanitase is under investigation for the treatment of Chronic Kidney Disease. …
Displaying drugs 10176 - 10200 of 10874 in total